AY

Alethia Young

#417 out of 1697 analysts
Cantor Fitzgerald
Automatically Tracked
Tracking: 0 Updated: Jul 29 at 07:45 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
21.33%
Gain
Monthly
0.75%
Yearly
9.34%
Drawdown
42.03%
$191,571.62
Equity
Holdings
$0
Cash
$191,571.62
Investment
$0
$91,077.29
Profit
Realized
$91,077.29
Unrealized
$0
Dividends
$4,149.76
$191,571.62
Cash
Deposits
$100,494.33
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$0
Win %
0%
This Week
Compared To Last Week
Gain
-5.42%
Profit
-$10,983.88
Win %
0%
This Month
Compared to last month
Gain
-17.43%
Profit
-$40,436.23
Win %
0%
This Year
Compared to last year
Gain
-17.29%
Profit
-$40,047.42
Win %
0%
Alx Oncology Holdings Inc. logo
ALXO Alx Oncology Holdings Inc.
+$67,972.81
AnaptysBio Inc. logo
ANAB AnaptysBio Inc.
+$41,634.02
Curis Inc. logo
CRIS Curis Inc.
+$26,946.55
Verastem Inc. logo
VSTM Verastem Inc.
+$15,617.59
TG Therapeutics, Inc. logo
TGTX TG Therapeutics, Inc.
+$7,372.19
Agios Pharmaceuticals Inc. logo
AGIO Agios Pharmaceuticals Inc.
+$7,042.4
Vertex Pharmaceuticals Incorporated logo
VRTX Vertex Pharmaceuticals Incorporated
+$6,138.64
Amgen Inc. logo
AMGN Amgen Inc.
+$5,311.13
Biomarin Pharmaceutical Inc. logo
BMRN Biomarin Pharmaceutical Inc.
+$4,363.49
Intellia Therapeutics Inc. logo
NTLA Intellia Therapeutics Inc.
+$4,059.65
PTC Therapeutics, Inc. logo
PTCT PTC Therapeutics, Inc.
+$2,985.64
Cencora, Inc. logo
COR Cencora, Inc.
+$2,751.92
Incyte Corporation logo
INCY Incyte Corporation
+$2,724.78
Arrowhead Pharmaceuticals Inc. logo
ARWR Arrowhead Pharmaceuticals Inc.
-$41,000.34
Arcus Biosciences Inc. logo
RCUS Arcus Biosciences Inc.
-$13,951.59
Fate Therapeutics Inc. logo
FATE Fate Therapeutics Inc.
-$12,586.21
Eledon Pharmaceuticals Inc. logo
ELDN Eledon Pharmaceuticals Inc.
-$7,807.15
Ascendis Pharma A/S logo
ASND Ascendis Pharma A/S
-$6,828.03
Puma Biotechnology Inc. logo
PBYI Puma Biotechnology Inc.
-$6,213.44
Alnylam Pharmaceuticals Inc logo
ALNY Alnylam Pharmaceuticals Inc
-$5,358.43
Gilead Sciences Inc. logo
GILD Gilead Sciences Inc.
-$4,618.6
Aurinia Pharmaceuticals Inc. logo
AUPH Aurinia Pharmaceuticals Inc.
-$2,507.59
Sarepta Therapeutics Inc. logo
SRPT Sarepta Therapeutics Inc.
-$2,269.47
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
-$702.68
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
317
Longs Won
183/316 57%
Profit Factor
1.46
Profitability
Shorts Won
0/1 0%
Standard Deviation
$4,160.84
Average Win
$1,513.01
Best Trade
(Dec 21) $36,921.77
Sharpe Ratio
-92.68
Average Loss
-$1,417.57
Worst Trade
(Sep 28) -$40,047.42
Z-Score
-3.48 (100%)
Commissions
$0
Avg. Trade Length
1m 3w
Expectancy
$287.31
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% 0.05% 0.31% 1.28% 4.02% 10.61% 24.57% 51.54%
Consecutive Losing Trades 135 122 108 95 81 68 54 41 27 14
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV